• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Device Problem Defective Device (2588)
Patient Problems Granuloma (1876); Fibrosis (3167)
Event Date 10/01/2022
Event Type  malfunction  
Manufacturer Narrative
Block b3: approximated based on the date the article was published.Block d4, h4: the device upn and lot number are unknown; therefore, the lot expiration and device manufacture dates are unknown.Block g2: literature source satoi s, et.Al.(2022).Foreign body reaction following use of submucosal lifting agent for endoscopic resections.The american journal of gastroenterology.117 (10s): e2154-e2154.Doi: 10.14309/01.Ajg.0000870280.04417.E5 block h6: impact codes f1001 capture the reportable event of aborted procedure.
 
Event Description
Boston scientific became aware of an event involving orise gel through the article, foreign body reaction following use of submucosal lifting agent for endoscopic resections, by sera satoi, et al.Per the article, the patient underwent endoscopic mucosal resection (emr) procedure in the duodenum.Tissue was lifted by submucosal injection of 4 ml orise gel; however, the procedure was aborted because the center of the polyp was fixed and could not be lifted.65 days later, the patient underwent repeat esophagogastroduodenoscopy (edg) to remove the lesion.Orise gel was attempted; however, the lesion could not be lifted due to severe fibrosis thus hybrid emr was used to excise the lesion.Pathologic examination revealed fragments of adenoma.In addition, submucosa showed foreign material with associated foreign giant cell reaction, consistent with the site prior to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17932951
MDR Text Key325712054
Report Number3005099803-2023-05458
Device Sequence Number1
Product Code PLL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 10/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/21/2023
Initial Date FDA Received10/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Removal/Correction Number92970101
Patient Sequence Number1
Patient Age72 YR
Patient SexMale
-
-